These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 35447103

  • 1. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
    Sharma M, Tollefsbol TO.
    Exp Cell Res; 2022 Jul 01; 416(1):113160. PubMed ID: 35447103
    [Abstract] [Full Text] [Related]

  • 2. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
    Paul B, Li Y, Tollefsbol TO.
    Int J Mol Sci; 2018 Jun 13; 19(6):. PubMed ID: 29899271
    [Abstract] [Full Text] [Related]

  • 3. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.
    Royston KJ, Udayakumar N, Lewis K, Tollefsbol TO.
    Int J Mol Sci; 2017 May 19; 18(5):. PubMed ID: 28534825
    [Abstract] [Full Text] [Related]

  • 4. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.
    Royston KJ, Paul B, Nozell S, Rajbhandari R, Tollefsbol TO.
    Exp Cell Res; 2018 Jul 01; 368(1):67-74. PubMed ID: 29689276
    [Abstract] [Full Text] [Related]

  • 5. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
    Abbas A, Hall JA, Patterson WL, Ho E, Hsu A, Al-Mulla F, Georgel PT.
    Biochem Cell Biol; 2016 Feb 01; 94(1):71-81. PubMed ID: 26458818
    [Abstract] [Full Text] [Related]

  • 6. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
    Meeran SM, Patel SN, Tollefsbol TO.
    PLoS One; 2010 Jul 06; 5(7):e11457. PubMed ID: 20625516
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
    Li Y, Meeran SM, Patel SN, Chen H, Hardy TM, Tollefsbol TO.
    Mol Cancer; 2013 Feb 04; 12():9. PubMed ID: 23379261
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
    Kala R, Shah HN, Martin SL, Tollefsbol TO.
    BMC Cancer; 2015 Oct 12; 15():672. PubMed ID: 26459286
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.
    Martin SL, Kala R, Tollefsbol TO.
    Curr Cancer Drug Targets; 2018 Oct 12; 18(1):97-106. PubMed ID: 28176652
    [Abstract] [Full Text] [Related]

  • 10. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs.
    Okonkwo A, Mitra J, Johnson GS, Li L, Dashwood WM, Hegde ML, Yue C, Dashwood RH, Rajendran P.
    Mol Nutr Food Res; 2018 Sep 12; 62(18):e1800228. PubMed ID: 29924908
    [Abstract] [Full Text] [Related]

  • 11. A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms.
    Rahman MM, Wu H, Tollefsbol TO.
    Sci Rep; 2024 May 27; 14(1):12091. PubMed ID: 38802425
    [Abstract] [Full Text] [Related]

  • 12. Sulforaphane and iberin are potent epigenetic modulators of histone acetylation and methylation in malignant melanoma.
    Mitsiogianni M, Trafalis DT, Franco R, Zoumpourlis V, Pappa A, Panayiotidis MI.
    Eur J Nutr; 2021 Feb 27; 60(1):147-158. PubMed ID: 32215717
    [Abstract] [Full Text] [Related]

  • 13. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications.
    Meeran SM, Patel SN, Li Y, Shukla S, Tollefsbol TO.
    PLoS One; 2012 Feb 27; 7(5):e37748. PubMed ID: 22662208
    [Abstract] [Full Text] [Related]

  • 14. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells.
    Sundaram MK, Ansari MZ, Al Mutery A, Ashraf M, Nasab R, Rai S, Rais N, Hussain A.
    Anticancer Agents Med Chem; 2018 Feb 27; 18(3):412-421. PubMed ID: 28925878
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase activity and vitamin D-dependent gene expressions in relation to sulforaphane in human breast cancer cells.
    Hossain S, Liu Z, Wood RJ.
    J Food Biochem; 2020 Feb 27; 44(2):e13114. PubMed ID: 31846091
    [Abstract] [Full Text] [Related]

  • 16. The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.
    Abbaoui B, Telu KH, Lucas CR, Thomas-Ahner JM, Schwartz SJ, Clinton SK, Freitas MA, Mortazavi A.
    J Proteomics; 2017 Mar 06; 156():94-103. PubMed ID: 28132875
    [Abstract] [Full Text] [Related]

  • 17. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
    Yang F, Wang F, Liu Y, Wang S, Li X, Huang Y, Xia Y, Cao C.
    Life Sci; 2018 Nov 15; 213():149-157. PubMed ID: 30352240
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
    Clarke JD, Hsu A, Yu Z, Dashwood RH, Ho E.
    Mol Nutr Food Res; 2011 Jul 15; 55(7):999-1009. PubMed ID: 21374800
    [Abstract] [Full Text] [Related]

  • 19. Dietary histone deacetylase inhibitors: from cells to mice to man.
    Dashwood RH, Ho E.
    Semin Cancer Biol; 2007 Oct 15; 17(5):363-9. PubMed ID: 17555985
    [Abstract] [Full Text] [Related]

  • 20. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
    Cao C, Wu H, Vasilatos SN, Chandran U, Qin Y, Wan Y, Oesterreich S, Davidson NE, Huang Y.
    Int J Cancer; 2018 Sep 15; 143(6):1388-1401. PubMed ID: 29633255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.